What does it take for agentic AI to become a trusted capability in regulated industries? At Swiss Biotech Day 2026, Basilea Pharmaceutica and Luzsana Biotechnology Europe AG discussed how agentic AI is delivering in trial execution today, and what realistically comes next. Together with PSI and Arango, we contributed to a discussion focused on real-world deployment challenges, including operational impact, data readiness, and how organizations can evaluate AI performance at scale. A pragmatic view on what it takes to move AI from experimentation to execution. Watch the discussion here: https://bit.ly/4wJVE3v #AgenticAI #DataStrategy #DigitalTransformation #SwissBiotechDay
Basilea Pharmaceutica and Luzsana Biotechnology Europe AG evaluated agentic AI directly in live development programs, then reported back on what actually changed. PSI moderated that conversation at Swiss Biotech Day 2026, alongside AI technologists from Arango and DataArt. The 45-minute panel covers where AI has shifted real trial outcomes, where early deployments fell short of expectations, and what data infrastructure gaps are blocking the next phase of adoption. Watch the full recording here: https://bit.ly/4wJVE3v #AgenticAI #ClinicalTrials #ClinicalOperations #DrugDevelopment #SwissBiotechDay